![]() |
市场调查报告书
商品编码
1784630
欧洲抗菌手术缝线市场报告(2021-2031 年,范围、细分、动态和竞争分析)Europe Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
欧洲抗菌手术缝线市场规模预计将从 2023 年的 1.1972 亿美元增加到 2031 年的 2.5211 亿美元。预计 2024 年至 2031 年期间该市场的复合年增长率为 9.8%。
执行摘要和欧洲抗菌手术缝合线市场分析:
欧洲抗菌手术缝线市场细分为德国、法国、英国、西班牙、义大利和欧洲其他地区。欧洲在全球抗菌手术缝线市场中占据第二位,预计在预测期内将保持强劲成长。由于心血管手术、普通手术和骨科手术的兴起,市场参与者越来越关注抗菌手术缝合线的生产,从而推动市场成长。
欧洲抗菌手术缝线市场細項分析:
有助于得出抗菌手术缝线市场分析的关键部分是类型、原材料、应用和最终用户。
根据类型,欧洲抗菌手术缝线市场分为三氯生抗菌缝线和氯己定抗菌缝线。 2023年,三氯生抗菌缝线占据了较大的市场份额。
根据原料,欧洲抗菌手术缝线市场细分为聚乳酸910抗菌缝线、聚卡普隆25和聚乙醇酸。聚乳酸910抗菌缝合线在2023年占据了最大的市场份额。
根据应用,欧洲抗菌手术缝线市场细分为心血管外科、一般外科、眼科外科、妇科外科、骨科外科、整形外科、兽医外科、牙科外科等。心血管外科在2023年占据了最大的市场。
根据最终用户,欧洲抗菌手术缝线市场分为医院、门诊手术中心和其他。 2023年,医院占据了最大的市场。
欧洲抗菌手术缝合线市场展望
除了锐器伤外,全球其他类型的工伤或职业伤害数量也不断增加。根据国际劳工组织的数据,每年约有230万人遭受工伤,影响他们的健康和生活品质。慢性伤口负担的不断增加最终推动了对先进伤口护理管理方法的需求,以大幅减轻国家医疗系统的财务负担。各国在治疗伤口和规避相关风险方面投入了大量资金。因此,随着慢性伤口发生率的上升,全球对抗菌手术缝线的需求也不断增加。
此外,全球医疗机构进行的一般外科手术、心血管外科手术、骨科手术、妇科手术和癌症手术数量正在急剧增加。此外,老年人口的增长也导致了一些严重的健康问题(例如疝气和白内障),这些问题需要手术作为主要治疗方案。老年人易患心血管疾病、骨科疾病、代谢性疾病及神经系统疾病等。根据世界卫生组织估计,全球老龄人口可能会从 2019 年的约 10 亿增加到 2050 年的约 21 亿。美容手术在娱乐业的从业人员中也变得很普遍。这些手术适用于患有意外或先天畸形的患者,以及希望让自己的外表更具吸引力的患者。因此,医院或类似医疗机构中手术数量的激增正在推动对抗菌手术缝合线的需求。
欧洲抗菌手术缝合线市场国家洞察
按国家划分,欧洲抗菌手术缝线市场包括德国、法国、英国、义大利、西班牙和欧洲其他地区。德国在2023年占最大份额。
由于手术部位感染 (SSI) 和抗生素抗药性细菌发病率不断上升,医疗机构对感染预防和控制措施的需求不断增长,成为市场的主要驱动力。 Avidicare 最近在《研究文章》上发表的一项研究数据显示,儘管法律和指南十分严格,但德国的手术部位感染 (SSI) 在 2008 年至 2016 年期间并未下降。基于 400 万名患者的实际医院报销资料,研究期间的 SSI 总盛行率为 4.9%。研究人员得出结论,与德国医院基于自愿性医院感染监测系统 (Krankenhaus-Infektions-Surveillance-System) 报告的 1.08% 的 SSI 发生率相比,SSI 的实际发生率被大大低估。
医疗保健专业人员日益认识到抗菌缝合线在减少手术部位感染 (SSI) 和改善患者预后的益处,这促进了这些缝合线的推广应用。德国优惠的报销政策和高昂的医疗支出也使医院和诊所能够采用先进的缝合技术。德国完善的医疗保健体系和每年大量的外科手术对抗菌缝合线的需求很高。此外,严格的感染控制监管框架和指南也推动抗菌缝合线成为一项标准护理。德国企业持续进行研发活动,不断推出创新抗菌缝线产品,进一步推动市场成长。
欧洲抗菌手术缝线市场公司简介
市场上一些主要的参与者包括TI Medical;Healthium Medtech Limited;Meril Life Sciences Pvt Ltd;Unilene;强生;Futura Surgicare Pvt Ltd(Dolphin Sutures);Cencora, Inc.(AmerisourceBergen Corporation);Advanced MedTech Solutions Pvt. Ltd.;以及Internacional Farmaceutica 等。这些参与者正在采取各种策略,例如扩张、产品创新和併购,以便为消费者提供创新产品并增加市场份额。
欧洲抗菌手术缝合线市场研究方法:
本报告中的资料收集和分析遵循了以下方法:
二手资料研究:研究流程始于全面的二手资料研究,利用内部和外部资源收集每个市场的定性和定量资料。常用的二手资料研究来源包括但不限于:
公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业期刊及其他相关出版品。政府文件、统计资料库和市场报告。针对在市场运营的公司的新闻文章、新闻稿和网路广播。註:公司简介部分所包含的所有财务资料均已标准化为美元。对于以其他货币报告的公司,数据已使用相应年份的相关汇率转换为美元。
一手研究 Insight Partners 每年都会与行业利益相关者和专家进行大量的一手调查,以验证其资料分析,并获得宝贵的见解。这些研究访谈旨在:
验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、成长模式、竞争动态和未来前景。一手资料研究透过电子邮件互动和电话访谈进行,涵盖不同地区的各种市场、类别、细分市场和次细分市场。参与者通常包括:
产业利害关係人:副总裁、业务发展经理、市场情报经理和国家销售经理外部专家:估值专家、研究分析师和具有行业专业知识的关键意见领袖
The Europe antimicrobial surgical suture market size is expected to reach US$ 252.11 million by 2031 from US$ 119.72 million in 2023. The market is estimated to record a CAGR of 9.8% from 2024-2031.
Executive Summary and Europe Antimicrobial Surgical Suture Market Analysis:
The Europe antimicrobial surgical suture market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Europe occupies the second position in the global antimicrobial surgical suture market and is expected to register a robust growth rate over the forecast period. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in cardiovascular surgeries, general surgeries, and orthopedic surgeries is leading to market growth.
Europe Antimicrobial Surgical Suture Market Segmentation Analysis:
Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.
Based on type, the Europe antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.
By raw materials, the Europe antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.
By application, the Europe antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.
By end user, the Europe antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.
Europe Antimicrobial Surgical Suture Market Outlook
Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.
Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.
Europe Antimicrobial Surgical Suture Market Country Insights
Based on country, the Europe antimicrobial surgical suture market comprises Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.
The increasing demand for infection prevention and control measures in healthcare settings is a primary market driver, owing to the rising incidence of surgical site infections (SSIs) and antibiotic-resistant bacteria. Data from a recent study published in Research Article by Avidicare indicate that despite stringent laws and guidelines, surgical site infections (SSIs) in Germany did not decline between 2008 and 2016. Based on real hospital reimbursement data from 4 million patients, the study period's total SSI prevalence was 4.9%. The researchers conclude that the actual number of SSIs has been greatly underestimated compared to the self-reported 1.08% SSI rates for German hospitals based on the voluntary Krankenhaus-Infektions-Surveillance-System.
The growing awareness among healthcare professionals about the benefits of antimicrobial sutures in reducing SSIs and improving patient outcomes is contributing to the adoption of these sutures. Favorable reimbursement policies and high healthcare expenditure in Germany also enable hospitals and clinics to adopt advanced suturing technologies. The country's well-established healthcare system and many annual surgical procedures create a high demand for antimicrobial sutures. Furthermore, stringent regulatory frameworks and guidelines for infection control are driving the adoption of antimicrobial sutures as a standard of care. Ongoing research and development activities by companies in the country are leading to the introduction of innovative antimicrobial suture products, further fueling market growth.
Europe Antimicrobial Surgical Suture Market Company Profiles
Some of the key players operating in the market include TI Medical; Healthium Medtech Limited; Meril Life Sciences Pvt Ltd; Unilene; Johnson & Johnson; Futura Surgicare Pvt Ltd (Dolphin Sutures); Cencora, Inc. (AmerisourceBergen Corporation); Advanced MedTech Solutions Pvt. Ltd.; and Internacional Farmaceutica SA among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Antimicrobial Surgical Suture Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise